ArticleCurrent issues in molecular biology2025
Hepatitis B Virus Genotypes and Subgenotypes Circulating in Belarus.
Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Approximately 800-900 new cases of chronic forms of hepatitis B are reported in Belarus annually. Compulsory vaccination, introduced to the country in the mid-90s, produces a certain positive effect on reducing the number of HBV cases. However, around 75,000 patients with chronic hepatitis B are estimated to live in the country at the moment. The main goal of this research was to determine the genotypes/subgenotypes of the hepatitis B virus and establish their role in maintaining the epidemic process in the country. Serological (CMIA, ELISA), molecular biological (PCR, sequencing), and bioinformatic (phylogenetic analysis) methods have been used to obtain results. As studies have shown, in 722 (81.7%) samples, genotype D has been determined; in 156 (17.7%), genotype A; in 3 (0.3%), genotype C; and only in 1 sample (0.1%), genotype B. In two cases (0.2%), a recombinant form of the hepatitis B virus has been detected. The epidemic process of hepatitis B in the country is supported mainly by the circulation of "local" variants of the virus. At the same time, there are occasional introductions of new genetic variants from outside of the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.